FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1643991689> ?p ?o ?g. }

• W1643991689 endingPage "9115" @default.
• W1643991689 startingPage "9107" @default.
• W1643991689 abstract "Ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] was shown to prolong the action of L-3,4-dihydroxyphenylalanine (L-DOPA) while suppressing dyskinesia in a single patient with Parkinson's disease (PD). The clinical basis of this effect of MDMA is unknown but may relate to its actions on either dopaminergic or serotoninergic systems in brain. In normal, drug-naive common marmosets, MDMA administration suppressed motor activity and exploratory behavior. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated, L-DOPA-primed common marmosets, MDMA transiently relieved motor disability but over a period of 60 min worsened motor symptoms. When given in conjunction with L-DOPA, however, MDMA markedly decreased dyskinesia by reducing chorea and to a lesser extent dystonia and decreased locomotor activity to the level observed in normal animals. MDMA similarly alleviated dyskinesia induced by the selective dopamine D2/3 agonist pramipexole. The actions of MDMA appeared to be mediated through 5-HT mechanisms because its effects were fully blocked by the selective serotonin reuptake inhibitor fluvoxamine. Furthermore, the effect of MDMA on L-DOPA-induced motor activity and dyskinesia was partially inhibited by 5-HT1a/b antagonists. The ability of MDMA to inhibit dyskinesia results from its broad spectrum of action on 5-HT systems. Serotoninergic receptors appear to play an important modulatory role in l-DOPA-induced dyskinesia, and this study may provide a framework for the use of serotoninergic agents in the treatment of L-DOPA-induced dyskinesia." @default.
• W1643991689 created "2016-06-24" @default.
• W1643991689 creator A5013470252 @default.
• W1643991689 creator A5030909442 @default.
• W1643991689 creator A5042956066 @default.
• W1643991689 creator A5044111267 @default.
• W1643991689 creator A5076278333 @default.
• W1643991689 date "2003-10-08" @default.
• W1643991689 modified "2023-10-17" @default.
• W1643991689 title "3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates" @default.
• W1643991689 cites W1211550181 @default.
• W1643991689 cites W1533710606 @default.
• W1643991689 cites W154014049 @default.
• W1643991689 cites W1964030516 @default.
• W1643991689 cites W1966860657 @default.
• W1643991689 cites W1973694510 @default.
• W1643991689 cites W1980185092 @default.
• W1643991689 cites W1980548191 @default.
• W1643991689 cites W1981869913 @default.
• W1643991689 cites W1985256582 @default.
• W1643991689 cites W1994094794 @default.
• W1643991689 cites W2001854690 @default.
• W1643991689 cites W2003744344 @default.
• W1643991689 cites W2009518623 @default.
• W1643991689 cites W2013972178 @default.
• W1643991689 cites W2016947344 @default.
• W1643991689 cites W2017452511 @default.
• W1643991689 cites W2025735527 @default.
• W1643991689 cites W2040286544 @default.
• W1643991689 cites W2050484443 @default.
• W1643991689 cites W2054741015 @default.
• W1643991689 cites W2070290419 @default.
• W1643991689 cites W2081299043 @default.
• W1643991689 cites W2081817881 @default.
• W1643991689 cites W2085861484 @default.
• W1643991689 cites W2095188030 @default.
• W1643991689 cites W2097227947 @default.
• W1643991689 cites W2110669693 @default.
• W1643991689 cites W2114784237 @default.
• W1643991689 cites W2132011251 @default.
• W1643991689 cites W2137292290 @default.
• W1643991689 cites W2147977831 @default.
• W1643991689 cites W2272492541 @default.
• W1643991689 cites W2305726828 @default.
• W1643991689 cites W2417725867 @default.
• W1643991689 cites W4247829567 @default.
• W1643991689 cites W2056728436 @default.
• W1643991689 doi "https://doi.org/10.1523/jneurosci.23-27-09107.2003" @default.
• W1643991689 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6740822" @default.
• W1643991689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14534244" @default.
• W1643991689 hasPublicationYear "2003" @default.
• W1643991689 type Work @default.
• W1643991689 sameAs 1643991689 @default.
• W1643991689 citedByCount "102" @default.
• W1643991689 countsByYear W16439916892012 @default.
• W1643991689 countsByYear W16439916892013 @default.
• W1643991689 countsByYear W16439916892014 @default.
• W1643991689 countsByYear W16439916892015 @default.
• W1643991689 countsByYear W16439916892016 @default.
• W1643991689 countsByYear W16439916892017 @default.
• W1643991689 countsByYear W16439916892018 @default.
• W1643991689 countsByYear W16439916892019 @default.
• W1643991689 countsByYear W16439916892020 @default.
• W1643991689 countsByYear W16439916892021 @default.
• W1643991689 countsByYear W16439916892022 @default.
• W1643991689 countsByYear W16439916892023 @default.
• W1643991689 crossrefType "journal-article" @default.
• W1643991689 hasAuthorship W1643991689A5013470252 @default.
• W1643991689 hasAuthorship W1643991689A5030909442 @default.
• W1643991689 hasAuthorship W1643991689A5042956066 @default.
• W1643991689 hasAuthorship W1643991689A5044111267 @default.
• W1643991689 hasAuthorship W1643991689A5076278333 @default.
• W1643991689 hasBestOaLocation W16439916891 @default.
• W1643991689 hasConcept C118552586 @default.
• W1643991689 hasConcept C126322002 @default.
• W1643991689 hasConcept C137183658 @default.
• W1643991689 hasConcept C15744967 @default.
• W1643991689 hasConcept C169760540 @default.
• W1643991689 hasConcept C170493617 @default.
• W1643991689 hasConcept C2775864247 @default.
• W1643991689 hasConcept C2779134260 @default.
• W1643991689 hasConcept C2779488553 @default.
• W1643991689 hasConcept C2779734285 @default.
• W1643991689 hasConcept C2779989193 @default.
• W1643991689 hasConcept C2780304432 @default.
• W1643991689 hasConcept C2780405171 @default.
• W1643991689 hasConcept C2780876324 @default.
• W1643991689 hasConcept C37000724 @default.
• W1643991689 hasConcept C513476851 @default.
• W1643991689 hasConcept C71924100 @default.
• W1643991689 hasConcept C98274493 @default.
• W1643991689 hasConceptScore W1643991689C118552586 @default.
• W1643991689 hasConceptScore W1643991689C126322002 @default.
• W1643991689 hasConceptScore W1643991689C137183658 @default.
• W1643991689 hasConceptScore W1643991689C15744967 @default.
• W1643991689 hasConceptScore W1643991689C169760540 @default.
• W1643991689 hasConceptScore W1643991689C170493617 @default.
• W1643991689 hasConceptScore W1643991689C2775864247 @default.

• next